Correction
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
Paper Information
Record ID:
19347
Author(s):
David M Hyman
Igor Puzanov
Vivek Subbiah
Jason E Faris
Ian Chau
Jean Yves Blay
Jurgen Wolf
Noopur S Raje
Eli L Diamond
Antoine Hollebecque
Radj Gervais
Maria Elena Elez-Fernandez
Anoitne Italiano
Ralf Dieter Hofheinz
Manuel Hidalgo
Emily Chan
Martin Schuler
Susan Frances Lasserre
Martina Makrutzki
Florin Sirzen
Maria Luisa Veronese
Josep Tabernero
Jose Baselga
Igor Puzanov
Vivek Subbiah
Jason E Faris
Ian Chau
Jean Yves Blay
Jurgen Wolf
Noopur S Raje
Eli L Diamond
Antoine Hollebecque
Radj Gervais
Maria Elena Elez-Fernandez
Anoitne Italiano
Ralf Dieter Hofheinz
Manuel Hidalgo
Emily Chan
Martin Schuler
Susan Frances Lasserre
Martina Makrutzki
Florin Sirzen
Maria Luisa Veronese
Josep Tabernero
Jose Baselga
Publication Date:
August 20, 2015
Retraction Date:
October 18, 2018
(7.1 years years ago)
Subjects:
Institutions:
- Memorial Sloan Kettering Cancer Center, New York, USA
- Vanderbilt University Medical Center, Nashville, USA
- University of Texas M.D. Anderson Cancer Center, Houston, USA
- Massachusetts General Hospital, Boston, USA
- Royal Marsden Hospital, Sutton, Surrey, United Kingdom
- Centre Léon Bérard, Lyon, France
- Institut Gustave Roussy, Villejuif, France
- Centre François Baclesse, Centre Hospitalier Universitaire Côte de Nacre, Caen, France
- Institut Bergonié Cancer Center, Bordeaux, France
- University Hospital of Cologne, Cologne
- Germany
- Universitätsmedizin Mannheim, Mannheim, West German Cancer Center, University Hospital Essen, Esse Germany
- n, Germany
- German Cancer Consortium, Heidelberg, Germany
- Vall d’Hebron University Hospital and Institute of Oncology, Universitat Autonoma de Barcelona, Barcelona, Spain
- Hospital Universitario Madrid Sanchinarro, Madrid, Spain
- F Hoffmann–La Roche, Basel, Switzerland
Article Type:
Publisher:
Massachusetts Medical Society
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (1528)
1528
Total Citations886
Post-Retraction(58.0%)
496
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
23
Within 30 days
160
Within 1 year
543
After 2+ years
2423
Days since retraction (latest)
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A First-in-Human Phase I Study of the ATP-Competit...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Unknown
Quick Stats
Total Citations:
1528
Years Since Retraction:
7.1 years
Open Access:
Yes
Last Checked:
Never